Cochrane · systematic review · CD004184

Evening versus morning dosing regimen drug therapy for hypertension

Wu, C, Zhao, P, Xu, P, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library

HypertensionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
4
No studies
2
Included studies
NR
No studies 2 · 33.3%Ungraded 0 · 0%Very low 4 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Evening versus morning dosing regimen for the treatment of hypertension

Population: adults with primary (essential) hypertension whose systolic or diastolic (or both) blood pressure levels were 130/80 mmHg or greater
6 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality
Evening vs morning dosing regimen
RR 0.49 [0.04, 5.42]1 study · 735 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Cardiovascular mortality (time points not specified)
Evening vs morning dosing regimen
no estimate extractedNRNo studies
Cardiovascular morbidity (stroke, myocardial infarction, congestive heart failure, aortic aneurysm) (time points not specified)
Evening vs morning dosing regimen
no estimate extractedNRNo studies
Serious adverse events
Evening vs morning dosing regimen
RR 1.17 [0.53, 2.57]2 studies · 833 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Overall adverse events
Evening vs morning dosing regimen
RR 0.89 [0.67, 1.2]7 studies · 1541 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Withdrawals from treatment due to adverse events
Evening vs morning dosing regimen
RR 0.76 [0.47, 1.23]7 studies · 1777 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias